NOF Corporation (TYO:4403)
2,749.00
-9.00 (-0.33%)
Jul 24, 2026, 3:30 PM JST
NOF Corporation Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 257,967 | 257,967 | 238,310 | 222,252 | 217,709 | 192,642 |
Revenue Growth | 8.25% | 8.25% | 7.22% | 2.09% | 13.01% | 11.58% |
Gross Profit Gross Profit Growth | 89,093 | 89,093 | 85,154 | 79,490 | 75,943 | 68,929 |
Operating Income Operating Income Growth | 47,412 | 47,412 | 45,309 | 42,142 | 40,625 | 35,596 |
Net Income Net Income Growth | 40,550 | 40,550 | 36,497 | 33,990 | 33,973 | 26,690 |
Earnings Per Share EPS Growth | 176.34 | 176.34 | 153.88 | 141.17 | 139.01 | 107.92 |
EPS Growth | 14.60% | 14.60% | 9.00% | 1.56% | 28.80% | 15.43% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Pharmaceuticals, Medicals and Health Pharmaceuticals, Medicals and Health Growth | 51,022 | 51,022 | 49,144 | 54,994 | 48,828 | 41,038 |
Functional Chemicals Functional Chemicals Growth | 150,407 | 150,407 | 154,691 | 137,370 | 147,753 | 129,733 |
Unallocated Adjustment Unallocated Adjustment Growth | -15,267 | -15,267 | -13,818 | -12,947 | -17,408 | -16,933 |
Others Others Growth | 10,111 | 10,111 | 9,504 | 8,683 | 8,648 | 8,777 |
Explosives & Propulsion Explosives & Propulsion Growth | 61,693 | 61,693 | 38,788 | 34,152 | 29,888 | 30,026 |
Total Total Growth | 257,966 | 257,966 | 238,309 | 222,252 | 217,709 | 192,641 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 88,364 | 88,364 | 87,064 | 91,744 | 92,520 | 85,430 |
Total Debt Total Debt Growth | 5,139 | 5,139 | 5,041 | 5,165 | 4,843 | 5,629 |
Net Cash (Debt) Net Cash Growth | 83,225 | 83,225 | 82,023 | 86,579 | 87,677 | 79,801 |
Net Cash Growth | 1.47% | 1.47% | -5.26% | -1.25% | 9.87% | 16.12% |
Net Cash Per Share Net Cash Per Share Growth | 361.93 | 361.93 | 345.82 | 359.59 | 358.74 | 322.67 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 35,865 | 35,865 | 28,975 | 29,970 | 23,333 | 27,393 |
Capital Expenditures CapEx Growth | -14,391 | -14,391 | -16,336 | -17,748 | -6,219 | -7,416 |
Free Cash Flow Free Cash Flow Growth | 21,474 | 21,474 | 12,639 | 12,222 | 17,114 | 19,977 |
Free Cash Flow Growth | 69.90% | 69.90% | 3.41% | -28.59% | -14.33% | -19.27% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 34.54% | 34.54% | 35.73% | 35.77% | 34.88% | 35.78% |
Operating Margin | 18.38% | 18.38% | 19.01% | 18.96% | 18.66% | 18.48% |
Pretax Margin | 22.22% | 22.22% | 21.31% | 21.81% | 22.07% | 19.71% |
Profit Margin | 15.72% | 15.72% | 15.32% | 15.29% | 15.60% | 13.86% |
FCF Margin | 8.32% | 8.32% | 5.30% | 5.50% | 7.86% | 10.37% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 70.000 | 61.000 | 45.000 | 38.000 | 36.000 | 30.000 |
Dividend Per Share Growth | 40.00% | 35.56% | 18.42% | 5.56% | 20.00% | 12.50% |
Dividend Yield | 2.55% | 1.97% | 2.27% | 1.90% | 1.85% | 1.94% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 15.59 | 17.32 | 13.01 | 14.66 | 14.70 | 15.48 |
Forward PE | 15.13 | 17.19 | 12.62 | 14.86 | 15.58 | 14.92 |
P/FCF Ratio | 28.90 | 32.70 | 37.57 | 40.77 | 29.18 | 20.68 |
PS Ratio | 2.41 | 2.72 | 1.99 | 2.24 | 2.29 | 2.14 |